We are currently recruiting participants for the following clinical and non-treatment studies. Each study has age and other requirements and certain clinical exclusions. One advantage of participation is that subjects receive treatment that is free of charge and confidential. Some studies even provide payment to participants. Current Studies (please select the appropriate heading to learn more about the treatment or non-treatment studies) ALCOHOL TREATMENT STUDIES COCAINE TREATMENT STUDIES NON-TREATMENT STUDIES
If you are interested in any of these studies, please call the telephone number listed for that study.
More information on Clinical Trials at MUSC ALCOHOL TREATMENT STUDIES |
Clinical Trial Name: Adolescent Alcohol Treatment Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Principal Investigator: Deborah Deas, MD, MPH Project Coordinator: Natalie Johnson, MA Research Assistant: Courtney Merritt, BS Contact Person: Natalie Johnson, MA Contact Number: 876-5070 Study Medications: Naltrexone or Placebo Therapy: 12 weeks, after twelve week treatment phase, participants will return to the site at 6, 9, and 12 months for follow-up assessments. Age Requirement: 15-25 Clinical Trial Name: Gabapentin as an Adjunct to Naltrexone for Alcoholism Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Principal Investigator: Raymond Anton, MD Project Coordinator: Pat Latham, RN, PhD, CS Research Assistants: Allison Hardy, BS Contact Person: Pat Latham, RN, PhD, CS or Alicia Baros, PhD Contact Number: 792-1230 or 792-0073 Study Medications: Naltrexone/Placebo, Naltrexone/Gabapentin, or Placebo/Placebo Therapy: 16 weeks of individual Combine Behavioral Intervention Therapy Age Requirement: 18-70 COCAINE TREATMENT STUDIES |
Clinical Trial Name: Modafinil and CBT for Cocaine Addiction Funding Source: National Institute on Drug Abuse (NIDA) Principal Investigator: Robert Malcolm, MD Research Assistant: Kelley Barnes, BA Contact Person: Kristi Cochran Huebner, MPH or Melissa Michel, MEd Contact Number: 792-1901 Study Medications: Modafinil or Placebo Therapy: 8 weekly sessions of Cognitive Behavioral Therapy (CBT) Frequency of visits: Tri-weekly visits, 1-2 week screening period, 8 week treatment period and 2 follow-up visits. Age Requirement: 18-50 Clinical Trial Name: A Controlled Trial of N-Acetylcysteine for the Treatment of Cocaine Dependence Funding Source: National Institute on Drug Abuse (NIDA) Principal Investigator: Robert Malcolm, MD Project Coordinator: Kristi Cochran Huebner, MPH or Melissa Michel, MEd Research Assistant: Bill Lechner, BS Contact Person: Kristi Cochran Huebner, MPH or Melissa Michel, MEd Contact Number: 792-1901 Study Medications: N-Acetylcysteine or Placebo Therapy: Cognitive Behavioral Therapy (CBT) Frequency of visits: Tri-weekly visits Age Requirement: 18-60 CDAP also recruits participants for non-treatment laboratory studies. These studies help us learn about basic biological, genetic or behavioral aspects of alcohol use and abuse. Many of these studies provide payment to participants.
Study Name: Clinical Circuitry Underlying Methamphetamine Cue Craving and Cue Extinction Funding Source: National Institute on Drug Abuse (NIDA) Principal Investigator: Robert Malcolm, MD Project Coordinator: Kristi Cochran Huebner, MPH or Melissa Michel, MEd Research Assistant: Lindsay Rogers, BA Contact Person: Lindsay Rogers, BA Contact Number: 792-7515 Study Medications: None Therapy: None Age Requirement: 18-50 Study Name: Effects on Medication Treatment on Cue-Induced Brain Activation in Alcoholics Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Principal Investigator: Hugh Myrick, MD Project Coordinator: Scott Henderson, BA Contact Person: Scott Henderson, BA Contact Number: 792-5560 Study Medications: Aripiprazole/Gabapentin/Placebo Therapy: None Age Requirement: 21-65 Study Name: Evaluating the Genetic Variability of Naltrexone Response Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Principal Investigator: Raymond Anton, MD Project Coordinator: Konstantin Voronin, MD, PhD Research Assistant: Abraham Tiffany, BS Contact Person: Abraham Tiffany, BS Contact Number: 792-1222 Study Medications: Naltrexone/Placebo Therapy: None Age Requirement: 21-65 Study Name: Personality and Alcohol Preference Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Principal Investigator: Suzanne Thomas, PhD Research Assistant: Brooke Manger, BA Contact Person: Brooke Manger, BA Contact Number: 792-5811 Study Medications: None Therapy: None Age Requirement: 21-65 Study Name: Stress and Subsequent Drinking in Individuals with Different Drinking Motives Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA) Principal Investigator: Suzanne Thomas, PhD Research Assistant: Darby Jarrett, BS Contact Person: Darby Jarrett, BS Contact Number: 792-4406 Study Medications: None Therapy: None Age Requirement: 21-40
|